Julphar participates in the largest exhibition of otolaryngologists in the Middle East

Julphar participated in the largest meeting of otolaryngologists in the Middle East, the Annual Middle East Otolaryngology Conference and Exhibition, which took place from May 24th to 26th at the Dubai International Convention & Exhibition Centre.

The three-day Exhibition program included numerous workshops, information sessions, presentations and debates where leading experts shared with otolaryngology-specialized physicians’ updates and news on the latest available developments in the topics of otolaryngology, rhinology, audiology and head & neck surgery. 

“Our participation in the Annual Middle East Otolaryngology Conference and Exhibition was a good opportunity for Julphar to highlight the company’s portfolio that supports otolaryngologists in their mission to improve people’s quality of life in their segment,” said Dr. Hosam Badr, Marketing Director at Julphar. “During the Conference, the Adult Primary Care unit displayed at the booth Julphar brands targeting the disease areas of acute otitis media (AOM), acute bacterial sinusitis and tonsillopharyngitis – Julmentin® ( Amoxicillin/clavulanic acid), Cefuzime® (Cefuroxime), Triaxon® (Ceftriaxone) and Rinelon® (Mometasone furoate), to increase brand awareness on these products. We are indeed already well-established in this otolaryngology segment and we are now striving to increase this presence in the UAE.”

Julphar sponsored 15 doctors from the UAE to attend the regional platform as per its commitment to continuously support healthcare professionals (HCPs) in beneficiating from continuing and outstanding educational programs.